Simplify Logo
Triomics

Triomics

EHR data parsing with oncology LLMs

Machine Learning Model Evaluation Engineer

Full-Time
No salary listed
Mid
India
In Person

About the job

Requirements
  • 3–6+ years of experience in machine learning engineering, data science, model evaluation, machine learning quality assurance, applied natural language processing evaluation, or data-heavy quality engineering.
  • Strong Python and data analysis skills.
  • Strong understanding of precision, recall, F1, calibration, confidence thresholds, dataset splits, leakage, overfitting, statistical testing, and error analysis.
  • Experience building evaluation pipelines, benchmark suites, test harnesses, dashboards, or regression frameworks.
  • Ability to work with imperfect labels, annotation disagreement, clinical ambiguity, and hidden evaluation sets.
  • Ability to work independently, exercise judgment, and challenge releases when evidence is weak.
  • Clear written communication for release reports, incident analysis, and quality decisions.
Responsibilities
  • Build and maintain evaluation frameworks for clinical natural language processing, large language models, retrieval-augmented generation, information extraction, and structured abstraction systems.
  • Create and manage hidden test datasets that are not directly visible to model developers to reduce overfitting risk.
  • Define release metrics, regression thresholds, slice-based evaluation, failure-mode tracking, and release-blocker criteria.
  • Compare model versions and identify performance degradation across clinical segments, document types, clients, data sources, labels, and edge cases.
  • Work with Clinical AI Data Specialists to design gold sets, hidden test sets, adjudication workflows, and label quality checks.
  • Work with Research Engineers to understand model changes, expected behavior, and evaluation risks without compromising test-set independence.
  • Work with MLOps and Data Engineering to monitor production behavior, triage bugs, analyze incident impact, and prioritize fixes.
  • Create release-readiness reports before production deployment.
  • Build dashboards, scripts, and automated checks for evaluation, monitoring, regression testing, and model comparison.
  • Prioritize model bugs based on clinical severity, user impact, frequency, regression risk, and operational urgency.
Desired Qualifications
  • Experience with large language model evaluation, retrieval-augmented generation evaluation, extraction evaluation, clinical natural language processing, or healthcare machine learning.
  • Experience with model monitoring, production incident analysis, data drift, or observability.
  • Experience with MLflow, Weights & Biases, Evidently, Great Expectations, DeepEval, Ragas, pytest, Airflow, Prefect, or similar tools.
  • Clinical or biomedical natural language processing exposure.

About the company

Triomics uses generative AI to turn unstructured health-record data in oncology into actionable insights. Its OncoLLM analyzes doctor notes, PDFs, and lab results to extract relevant clinical information, with Prism automating patient-to-clinical-trial matching and Harmony curating EHR data for quality reporting and cohort analysis. By integrating with existing EHR systems, it speeds up tasks that used to require hours of manual review and can match patients to trials in minutes with high accuracy. The goal is to reduce manual data review in cancer research and care, accelerate trial enrollment, and support precision oncology for cancer centers, academic medical centers, and health systems.

Company Size

51-200

Company Stage

Series B

Total Funding

$54.2M

Headquarters

New York City, New York

Founded

2020

Get referred to Triomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Triomics raised $22 million in May 2026, bringing total funding above $36 million.
  • May 2026 reports say customers grew fourfold and annualized recurring revenue rose tenfold.
  • January 2026 Mount Sinai and October 2025 MSK deployments prove enterprise adoption momentum.

What critics are saying

  • Epic and Flatiron can bundle oncology workflow features and squeeze Triomics by 2027.
  • Model errors in trial matching trigger missed enrollments, compliance failures, and clinician distrust immediately.
  • If Battery's $22 million Series B fails to convert into durable ARR, Triomics stalls.

What makes Triomics unique

  • Triomics sells oncology-specific AI, not generic chart summarization, with source-backed outputs.
  • Its platform embeds trial matching, pre-charting, and registry abstraction inside clinician workflows.
  • MSK, MD Anderson, Yale, and Mount Sinai validate its oncology-specialized workflow moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Meal Benefits

Growth & Insights and Company News

Headcount

6 month growth

-6%

1 year growth

-9%

2 year growth

-10%
TechCrunch
May 27th, 2026
Triomics nabs $22M to bring oncology-specific AI to cancer centers | TechCrunch

The Series B round was led by Battery Ventures.

SVJ Media Ltd.
May 10th, 2024
Triomics Raises $15M for AI Trials

Triomics, a generative AI startup, has secured $15M in Series A funding to enhance cancer clinical trials matching. Founded by Sarim Khan and Hrituraj Singh, the company's OncoLLM platform uses AI to quickly match patients with trials, improving efficiency in cancer care. With this funding from Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator, Triomics plans to expand its reach and develop its platform further.

TechCrunch
May 9th, 2024
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each

Intelligence360 News
Mar 6th, 2023
Triomics Has Filed A Notice Of An Exempt Offering Of Securities To Raise $14,135,000.00 In New Equity Investment.

Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment. Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Triomics is raising $14,135,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Sarim Khan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About TriomicsTriomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny. Triomics Harmony© is powering a host of next-generation applications of healthcare data and systems for advancing clinical research by harnessing the growing maturity of US healthcare on FHIR and addressing its current limitations, enabling us to empower healthcare organizations at any phase of their FHIR adoption journey.To learn more about Triomics, visit http://www.triomics.in/Contact:Sarim Khan, Chief Executive Officer707-227-9112https://www.linkedin.com/in/sarim-khan-triomics/SOURCE: http://www.intelligence360.ioCopyright (c) 2023 SI360 Inc. All rights reserved